Position in TRVI
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$28,807,610
-$9,352,212 QoQ
Shares Held
1,544,644
-51.7% QoQ
Ownership
1.08%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#28
of 216 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TRVI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026VIKING GLOBAL INVESTORS LP holds $2,489,856,848 across 17 Biotechnology names. TRVI ranks #13 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
9,949,219 | $741,017,831 | |
| 2 | BMRN |
Biomarin Pharmaceutical Inc
|
7,616,563 | $435,819,734 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
6,271,467 | $221,947,217 | |
| 4 | MANE |
Veradermics, Inc
|
1,561,494 | $191,970,072 | |
| 5 | ORKA |
Oruka Therapeutics, Inc.
|
1,503,478 | $143,086,001 | |
| 6 | NAMS |
NewAmsterdam Pharma Co N.V.
|
4,203,567 | $142,458,885 | |
| 7 | SION |
Sionna Therapeutics, Inc.
|
3,195,181 | $140,556,012 | |
| 8 | PHVS |
Pharvaris N.V.
|
3,653,310 | $126,331,459 |
All Filings in TRVI
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $28,807,610 | 1,544,644 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $38,159,822 | 3,198,644 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $40,047,022 | 3,198,644 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $46,929,206 | 5,128,875 | Shares | Sole | 2025-11-14 | |
| 2025-09-30 | $46,929,206 | 5,128,875 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $41,056,146 | 7,505,694 | Shares | Sole | 2025-08-14 | |
| 2025-06-30 | $8,440,210 | 1,543,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $20,302,811 | 3,227,792 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $18,128,000 | 4,400,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $14,696,000 | 4,400,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $13,112,000 | 4,400,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $15,180,000 | 4,400,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $5,896,000 | 4,400,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $9,592,000 | 4,400,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $10,516,000 | 4,400,000 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $8,140,000 | 4,400,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $8,492,000 | 4,400,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $6,776,000 | 4,400,000 | Shares | Sole | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||